Go Pro
NASDAQ:MDBH

MDB Capital Q2 2024 Earnings Report

MDB Capital logo
$3.22 -0.05 (-1.38%)
Closing price 07/20/2026 03:59 PM Eastern
Extended Trading
$3.18 -0.03 (-1.09%)
As of 07/20/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MDB Capital EPS Results

Actual EPS
-$0.46
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

MDB Capital Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MDB Capital Announcement Details

Quarter
Q2 2024
Time
N/A
Conference Call Date
Tuesday, August 13, 2024
Conference Call Time
7:00AM ET

Earnings Documents

MDB Capital Earnings Headlines

MDB Capital (NASDAQ:MDBH) Trading Down 0.4% - Here's Why
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.tc pixel
See More MDB Capital Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MDB Capital? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MDB Capital and other key companies, straight to your email.

About MDB Capital

MDB Capital (NASDAQ:MDBH), through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.

View MDB Capital Profile